Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g 4 Regulatory News (MAV4)

Share Price Information for Maven I&g 4 (MAV4)

Share Price is delayed by 15 minutes
Get Live Data
50.00    0.00 (0.00%)
Bid:
49.00
Ask:
51.00
Spread: 2.00 (4.082%)
Market Cap: £83.71m
MAV4 Live PriceLast checked at - London Stock Exchange

Intraday Maven I&g 4 Share Chart

Interim Management Statement

18 Nov 2013 14:35

RNS Number : 3098T
Maven Income & Growth VCT 4 PLC
18 November 2013
 

Interim Management Statement

 

Maven Income and Growth VCT 4 PLC (the Company) - quarter ended 30 September 2013

 

This Interim Management Statement, for the quarter ended 30 September 2013, is provided in accordance with Rule 4.3 of the Disclosure and Transparency Rules of the UK Listing Authority and also includes relevant information in respect of the period from 1 October 2013 to the date of issue. This Statement has been prepared solely to provide additional information in order to meet the relevant requirements of the UK Listing Authority's Disclosure and Transparency Rules, and should not be relied on by Shareholders, or any other party, for any other purpose.

 

1.

Financial highlights

 

· Net asset value (NAV)1 of 96.00p per Ordinary Share and 101.01p per C Share at 30 September 2013, after payment of the interim dividend on the Ordinary Shares, compared to 97.60p and 98.40p per share respectively at 30 June 2013;

· NAV total return2 of 125.3p per Ordinary Share at 30 September 2013, compared to 124.9p at 30 June 2013; and

· Interim dividend of 2.00p per Ordinary Share in respect of the year ending 31 December 2013, paid on 27 September 2013.

 

1The NAV is unaudited and reflects the closing bid price of quoted securities at 30 September 2013. Unlisted companies are normally valued on a six-monthly basis and the NAV incorporates the Directors' valuation of unlisted investments as at 30 June 2013, adjusted for subsequent events where appropriate.

2NAV total return is the sum of NAV per share and dividends paid per share since launch.

 

2.

Investments and disposals

 

During the quarter ended 30 September 2013, a net amount of £139,826 was invested from the Ordinary Share portfolio in two unlisted companies; net proceeds of £402,967 were realised from the sale of short-dated UK treasury bills; a total of £432,553 of capital was returned from three unlisted companies against a cost of £508,811 and the full or partial disposals of four AIM quoted investments generated aggregate proceeds of £115,584 against a total cost of £103,855.

 

During the same period, the full or partial disposals of three AIM quoted investments from the C Share portfolio, generated aggregate proceeds of £48,118 against a total cost of £29,277.

 

3.

Recent developments

 

Between 1 October 2013 and the date of this Statement, £132,769 was invested in two unlisted companies; a total of £295,254 of capital was returned by two unlisted companies; and the partial disposal of an AIM quoted investment generated proceeds of £35,438 against a cost of £32,284.

 

In the same period, an investment of £112,000 in an unlisted company was made on behalf of the C Share portfolio and the sale of the unlisted investment in Espresso Group generated proceeds of £1,246,191. While the reduction of £253,809 against the carrying value of Espresso Group represents 6.5% of the net assets attributable to the C shares as at 30 September 2013, the Manager has taken the view that this was the optimum opportunity to secure an exit from a legacy investment acquired from the merger of the Company with Ortus VCT PLC earlier in 2013.

 

Other than as described above, and changes in the value of investments quoted on regulated markets, the Board is not aware of any material events during the period from 1 July 2013 to 30 September 2013, or in the period from 1 October 2013 to the date of this announcement, which would have had a material impact on the financial position of the Company.

 

Issued on behalf of the Board

 

Maven Capital Partners UK LLP

Secretary

 

18 November 2013

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSUWOSROOAAAAA
Date   Source Headline
9th Nov 20233:49 pmRNSResult of General Meeting
13th Oct 20234:56 pmRNSPublication of a Prospectus
13th Oct 202310:17 amRNSDirector/PDMR Shareholding
13th Oct 202310:15 amRNSIssue of Equity - Dividend Investment Scheme
6th Oct 20232:39 pmRNSStatement re Dividend Investment Scheme
8th Sep 20235:01 pmRNSTransaction in Own Shares-Corrective announcement
7th Sep 20233:35 pmRNSTransaction in Own Shares
30th Aug 20232:02 pmRNSHalf-year Report
17th Aug 20233:26 pmRNSStatement re NAV and Interim Dividend
12th Jul 20234:09 pmRNSHolding(s) in Company
10th Jul 20235:06 pmRNSHolding(s) in Company
2nd Jun 202310:05 amRNSDirector/PDMR Shareholding
2nd Jun 20239:43 amRNSIssue of Equity
24th May 20235:10 pmRNSTransaction in Own Shares
23rd May 202310:18 amRNSDirector/PDMR Shareholding
23rd May 202310:17 amRNSIssue of Equity - Dividend Investment Scheme
12th May 20233:38 pmRNSNet Asset Value(s) - Dividend Investment Scheme
11th May 20233:01 pmRNSResult of AGM
11th May 20232:20 pmRNSNet Asset Value(s)
27th Apr 20231:04 pmRNSIssue of Supplementary Prospectus
13th Apr 20237:00 amRNSAnnual Financial Report
5th Apr 202312:36 pmRNSDirector/PDMR Shareholding
5th Apr 202312:30 pmRNSIssue of Equity
29th Mar 20232:19 pmRNSIssue of Supplementary Prospectus
21st Mar 20234:08 pmRNSTransaction in Own Shares
3rd Mar 20239:56 amRNSIssue of Equity
21st Feb 20234:11 pmRNSUnaudited NAV and Proposed Final Dividend
21st Feb 20233:10 pmRNSUnaudited Net Asset Value, Proposed Final Dividend
16th Feb 20237:00 amRNSStatement re Offer for Subscription
8th Feb 202310:24 amRNSDirector/PDMR Shareholding
8th Feb 202310:17 amRNSDirector/PDMR Shareholding
8th Feb 20239:44 amRNSIssue of Equity
3rd Feb 20233:12 pmRNSProvisional Net Asset Value
23rd Nov 20224:53 pmRNSTransaction in Own Shares
10th Nov 20223:33 pmRNSNet Asset Value(s)
9th Nov 20223:02 pmRNSResult of General Meeting
7th Oct 20224:28 pmRNSPublication of a Prospectus
7th Oct 20229:58 amRNSDirector/PDMR Shareholding
7th Oct 20229:51 amRNSIssue of Equity
4th Oct 20223:30 pmRNSChange of Auditor
3rd Oct 20223:08 pmRNSStatement re Dividend Investment Scheme
6th Sep 20224:48 pmRNSTransaction in Own Shares
2nd Sep 20223:30 pmRNSHalf-year Report
19th Aug 202210:47 amRNSStatement re NAV and Interim Dividend
14th Jul 20229:33 amRNSDirectorate Change
8th Jul 20223:28 pmRNSStatement re Joint Offers for Subscription
24th Jun 20224:13 pmRNSDirectorate Change
9th Jun 20224:18 pmRNSTransaction in Own Shares
6th Jun 20222:15 pmRNSIssue of Equity
20th May 202210:09 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.